Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Targeting GPCR Signaling for Idiopathic Pulmonary Fibrosis Therapies.

Haak AJ, Ducharme MT, Diaz Espinosa AM, Tschumperlin DJ.

Trends Pharmacol Sci. 2020 Jan 30. pii: S0165-6147(19)30293-7. doi: 10.1016/j.tips.2019.12.008. [Epub ahead of print] Review.

PMID:
32008852
2.

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.

Haak AJ, Kostallari E, Sicard D, Ligresti G, Choi KM, Caporarello N, Jones DL, Tan Q, Meridew J, Diaz Espinosa AM, Aravamudhan A, Maiers JL, Britt RD Jr, Roden AC, Pabelick CM, Prakash YS, Nouraie SM, Li X, Zhang Y, Kass DJ, Lagares D, Tager AM, Varelas X, Shah VH, Tschumperlin DJ.

Sci Transl Med. 2019 Oct 30;11(516). pii: eaau6296. doi: 10.1126/scitranslmed.aau6296.

PMID:
31666402

Supplemental Content

Loading ...
Support Center